Clinical guidelines for diagnosing and managing ocular manifestations in children with mucopolysaccharidosis

Kristina T Fahnehjelm1, Jane L Ashworth, Susanne Pitz

  • 1Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. kristina.tear-fahnehjelm@sankterik.se

Acta Ophthalmologica
|December 6, 2011
PubMed

Insights

Mucopolysaccharidoses (MPS) cause vision problems in children, affecting various eye structures. Early diagnosis and management by ophthalmologists are crucial for improving quality of life.

Area of Science:

  • Ophthalmology
  • Genetics
  • Metabolic Disorders

Background:

  • Mucopolysaccharidoses (MPS) are rare genetic lysosomal storage disorders.
  • Characterized by glycosaminoglycan accumulation, leading to multisystemic clinical manifestations.
  • Severe cases can result in premature death.

Purpose of the Study:

  • To provide an overview of ocular problems in MPS.
  • To establish clinical guidelines for pediatric ophthalmologists.
  • To facilitate early diagnosis and management of ocular manifestations in children with MPS.

Main Methods:

  • Literature review on ocular manifestations in MPS.
  • Analysis of diagnostic challenges in MPS patients.
  • Review of management strategies for ocular complications.

Main Results:

  • Ocular problems are highly prevalent in children with MPS, affecting the cornea, retina, optic nerve, and visual pathways.
  • Diagnostic difficulties include corneal clouding hindering fundus visualization and falsely elevated intraocular pressures.
  • Simple interventions like prescription or photochromatic glasses can significantly enhance quality of life.

Conclusions:

  • Ocular manifestations are a significant concern in pediatric MPS.
  • Standardized diagnostic and management guidelines are needed for pediatric ophthalmologists.
  • Timely intervention can mitigate visual impairment and improve patient outcomes.

Related Concept Videos

Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Glycosaminoglycans01:23

Glycosaminoglycans

Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...